Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,920
Closed -$602K 961
2023
Q3
$602K Sell
5,920
-10,382
-64% -$1.09M ﹤0.01% 769
2023
Q2
$1.61M Buy
16,302
+1,119
+7% +$100K 0.01% 665
2023
Q1
$1.4M Buy
15,183
+2,284
+18% +$205K 0.01% 805
2022
Q4
$903K Sell
12,899
-7,469
-37% -$577K ﹤0.01% 916
2022
Q3
$1.48M Sell
20,368
-7,598
-27% -$611K 0.01% 811
2022
Q2
$1.97M Buy
27,966
+2,100
+8% +$154K 0.01% 829
2022
Q1
$2.08M Buy
+25,866
New +$2.33M 0.01% 835

Other funds holding ARCB

Aviva's ARCB Position: Q4 2023 in Review

Aviva sold out of ArcBest (ARCB) in Q4 2023, closing a stake of 5,920 shares — an estimated $602K sold.

Aviva first reported a position in ARCB in Q1 2022 and held it in 7 quarters. The position peaked at $2.08M in Q1 2022. 306 funds tracked by Wall St. Rank hold ARCB as of Q4 2023.

  • Aviva reported no remaining ArcBest position as of Q4 2023 after selling out during the quarter.
  • Aviva sold 5,920 ArcBest shares in Q4 2023, an estimated $602K.
  • Aviva first reported a position in ArcBest in Q1 2022 and held it in 7 quarters.
  • Aviva's ArcBest position peaked at $2.08M in Q1 2022.
  • 306 funds tracked by Wall St. Rank held ArcBest as of Q4 2023.

Based on Aviva's 13F filing for Q4 2023, filed 9 Feb 2024.